These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12493480)

  • 1. Interaction of immunosuppressive agents rapamycin and its analogue SDZ-RAD with endothelial P-gp.
    Laplante A; Demeule M; Murphy GF; Béliveau R
    Transplant Proc; 2002 Dec; 34(8):3393-5. PubMed ID: 12493480
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of a novel rapamycin analogon SDZ RAD on endothelial tissue factor and adhesion molecule expression.
    Haubitz M; Brunkhorst R
    Transplant Proc; 2002 Jun; 34(4):1124-6. PubMed ID: 12072294
    [No Abstract]   [Full Text] [Related]  

  • 3. The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats.
    Simler NR; Howell DC; Marshall RP; Goldsack NR; Hasleton PS; Laurent GJ; Chambers RC; Egan JJ
    Eur Respir J; 2002 Jun; 19(6):1124-7. PubMed ID: 12108867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDZ RAD. Rapamycin SDZ.
    Drugs R D; 1999 Jan; 1(1):97-9. PubMed ID: 10566000
    [No Abstract]   [Full Text] [Related]  

  • 5. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
    Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
    Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
    Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
    Crowe A; Lemaire M
    Pharm Res; 1998 Nov; 15(11):1666-72. PubMed ID: 9833985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
    Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
    J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
    Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
    Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of immunosuppressive drugs on T-cell motility.
    Datta A; David R; Glennie S; Scott D; Cernuda-Morollon E; Lechler RI; Ridley AJ; Marelli-Berg FM
    Am J Transplant; 2006 Dec; 6(12):2871-83. PubMed ID: 17061998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SDZ RAD inhibits cold ischemia-induced vascular remodeling.
    Schuurman HJ; Pally C; Weckbecker G; Schuler W; Bruns C
    Transplant Proc; 1999; 31(1-2):1024-5. PubMed ID: 10083455
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats.
    Crowe A; Bruelisauer A; Duerr L; Guntz P; Lemaire M
    Drug Metab Dispos; 1999 May; 27(5):627-32. PubMed ID: 10220493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation.
    Ota H; Eto M; Ako J; Ogawa S; Iijima K; Akishita M; Ouchi Y
    J Am Coll Cardiol; 2009 Jun; 53(24):2298-305. PubMed ID: 19520256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
    Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
    Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
    Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
    Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
    Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
    J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
    Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral everolimus inhibits in-stent neointimal growth.
    Farb A; John M; Acampado E; Kolodgie FD; Prescott MF; Virmani R
    Circulation; 2002 Oct; 106(18):2379-84. PubMed ID: 12403670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
    Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein, CYP3A, and plasma carboxylesterase determine brain and blood disposition of the mTOR Inhibitor everolimus (Afinitor) in mice.
    Tang SC; Sparidans RW; Cheung KL; Fukami T; Durmus S; Wagenaar E; Yokoi T; van Vlijmen BJ; Beijnen JH; Schinkel AH
    Clin Cancer Res; 2014 Jun; 20(12):3133-45. PubMed ID: 24727322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.